P

Premia SA
F:3FDA

Watchlist Manager
Premia SA
F:3FDA
Watchlist
Price: 1.242 EUR -0.8% Market Closed
Market Cap: €107.3m

Wall St Price Targets

3FDA Price Forecast
Based on 3 analysts

+62% Upside
from €1.242 today

Premia SA (3FDA)’s 12-month stock price forecast through October 2027 has a consensus target of €2.013, implying 62% upside. The forecast is based on price targets from 3 Wall Street analysts.

3FDA Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for 3FDA yet.

Premia SA Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 3FDA's stock price target?
Price Target
2.013 EUR

According to Wall Street analysts, the average 1-year price target for 3FDA is 2.013 EUR with a low forecast of 1.894 EUR and a high forecast of 2.176 EUR.

What is the Revenue forecast for Premia SA?
Projected CAGR
14%

The compound annual growth rate for Revenue over the next 2 years is 14%.

What is the Operating Income forecast for Premia SA?
Projected CAGR
22%

The compound annual growth rate for Operating Income over the next 2 years is 22%.

What is the Pre-Tax Income forecast for Premia SA?
Projected CAGR
-23%

The compound annual growth rate for Pre-Tax Income over the next 2 years is -23%.

What is the Net Income forecast for Premia SA?
Projected CAGR
-21%

The compound annual growth rate for Net Income over the next 2 years is -21%.

Back to Top